Search

Your search keyword '"Siniscalchi, C"' showing total 174 results

Search Constraints

Start Over You searched for: Author "Siniscalchi, C" Remove constraint Author: "Siniscalchi, C"
174 results on '"Siniscalchi, C"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

10. Timing and characteristics of venous thromboembolism after noncancer surgery

11. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

12. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

13. Symptomatic subsegmental versus more central pulmonary embolism: Clinical outcomes during anticoagulation

14. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

15. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

16. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

17. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

18. Venous Thrombosis within 30 Days after Vaccination against SARS-CoV-2 in a Multinational Venous Thromboembolism Registry

19. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

20. Edoxaban for the Long‐Term Therapy of Venous Thromboembolism: Should the Criteria for Dose Reduction be Revised?

21. Liver status and outcomes in patients without previous known liver disease receiving anticoagulant therapy for venous thromboembolism

22. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

23. Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project

24. D-dimer levels and risk of recurrence following provoked venous thromboembolism: findings from the RIETE registry

25. Timing and characteristics of venous thromboembolism after noncancer surgery

26. Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry

27. Venous Thromboembolism in Patients With Autoimmune Disorders: Findings From the RIETE Registry

28. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

29. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

30. Characteristics, treatment patterns and outcomes of patients presenting with venous thromboembolic events after knee arthroscopy in the RIETE Registry

31. Systolic blood pressure and mortality in acute symptomatic pulmonary embolism

32. Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries: analysis from the RIETE registry

33. Prediction of early mortality in patients with cancer-associated thrombosis in the RIETE Database

34. Frequency and prognostic impact of acute kidney injury in patients with acute pulmonary embolism. Data from the RIETE registry

35. Venous thromboembolism in young adults: Findings from the RIETE registry

36. Statin and all-cause mortality in patients receiving anticoagulant therapy for venous thromboembolism. Data from the RIETE registry

37. Vena cava filters in patients presenting with major bleeding during anticoagulation for venous thromboembolism

38. Mortality after pulmonary embolism in patients with diabetes. Findings from the RIETE registry

39. Impact of sex, age, and risk factors for venous thromboembolism on the initial presentation of first isolated symptomatic acute deep vein thrombosis

40. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

41. Real-life Use of Anticoagulants in Venous Thromboembolism With a Focus on Patients With Exclusion Criteria for Direct Oral Anticoagulants

42. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

47. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

49. C4. Maternal cardiac changes during uncomplicated twin pregnancy: does the chorionicity matter?

Catalog

Books, media, physical & digital resources